[Clinical symptoms and molecular pathogenesis of Noonan syndrome--current concepts]

Med Wieku Rozwoj. 2006 Jan-Mar;10(1 Pt 2):289-308.
[Article in Polish]

Abstract

Noonan syndrome (NS; MIM 163950) is an autosomal dominant disorder. With incidence of 1/1000 to 1/2500 live births, NS belongs to the most common genetic disorders. Typical features of NS are: short stature, chest deformities, congenital heart defects, cryptorchidism and dysmorphic features. Mutations of PTPN11 gene (located on chromosome 12q24.1) are responsible for NS and are identified in 33-60% cases. Less than half of the cases are familial. This paper presents current opinion on clinical symptoms, molecular pathogenesis and possibilities of growth hormone therapy. The genotype--phenotype correlation is also discussed.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Abnormalities, Multiple / diagnosis
  • Abnormalities, Multiple / genetics
  • DNA Mutational Analysis
  • Genetic Therapy
  • Genotype
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics*
  • Mutation, Missense
  • Noonan Syndrome / diagnosis*
  • Noonan Syndrome / genetics*
  • Noonan Syndrome / therapy
  • Phenotype
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatases / genetics*
  • SH2 Domain-Containing Protein Tyrosine Phosphatases
  • src Homology Domains / genetics*

Substances

  • Intracellular Signaling Peptides and Proteins
  • PTPN11 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatases
  • SH2 Domain-Containing Protein Tyrosine Phosphatases